» Articles » PMID: 9739023

Various Regions Within the Alpha-helical Domain of the COL1A1 Gene Are Fused to the Second Exon of the PDGFB Gene in Dermatofibrosarcomas and Giant-cell Fibroblastomas

Overview
Date 1998 Sep 17
PMID 9739023
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Dermatofibrosarcoma protuberans (DFSP) and its juvenile form, giant-cell fibroblastoma (GCF), are uncommon infiltrative tumors of the dermis, which present unique cytogenetic features, such as the reciprocal translocation t(17;22) or, more commonly, supernumerary ring chromosomes containing sequences from chromosomes 17 and 22. We have recently shown that these aberrations are cytogenetic manifestations of gene fusions between the platelet-derived growth factor B-chain gene (PDGFB), the cellular equivalent of the v-sis oncogene, and the collagen type 1 alpha 1 gene (COL1A1), the major protein constituent of the extracellular matrix in connective tissue of skin. We now report characterization of COL1A1/PDGFB chimeric genes at the RNA and DNA sequence levels in a series of DFSPs and GCFs. All 16 tumors studied contained the COL1A1/PDGFB gene. The location of breakpoints within COL1A1 varied greatly, but was always limited to the region encoding the alpha-helical domain. The PDGFB segment of the chimeric transcript always starts with exon 2, placing PDGFB under the control of the COL1A1 promoter and removing all known elements negatively controlling PDGFB transcription and translation. Production of these aberrant transcripts in fibroblasts, the suspected cell of origin of DFSP/GCF, likely causes autocrine stimulation and cell proliferation. No specific function has yet been assigned to exon 2 of PDGFB, and this exon does not encode for the mature growth factor. Its retention in all chimeric COL1A1/PDGFB genes suggests that it is important for the normal processing of the PDGFB polypeptide.

Citing Articles

A Case of Pan-TRK Positive Dermatofibrosarcoma Protuberans Located on the Nose.

Teshima R, Hitaka T, Sugino H, Okada E, Sawada Y Cureus. 2024; 16(2):e54215.

PMID: 38496071 PMC: 10943253. DOI: 10.7759/cureus.54215.


Detection of various fusion genes by one-step RT-PCR and the association with clinicopathological features in 242 cases of soft tissue tumor.

Song L, Zhang Y, Wang Y, Xia Q, Guo D, Cao J Front Cell Dev Biol. 2023; 11:1214262.

PMID: 37621777 PMC: 10446835. DOI: 10.3389/fcell.2023.1214262.


A case of dermatofibrosarcoma protuberans with neurofibromatous change.

Kudoh K, Itabashi C, Arai E, Ohshika S, Mizukami H J Surg Case Rep. 2021; 2021(12):rjab472.

PMID: 34909162 PMC: 8666154. DOI: 10.1093/jscr/rjab472.


Dermatofibrosarcoma Protuberans: Update on the Diagnosis and Treatment.

Hao X, Billings S, Wu F, Stultz T, Procop G, Mirkin G J Clin Med. 2020; 9(6).

PMID: 32516921 PMC: 7355835. DOI: 10.3390/jcm9061752.


COL1A1-PDGFB gene fusion in dermatofibrosarcoma protuberans: a useful diagnostic tool and clinicopathological analysis.

Li N, Zhou T, Chen S, Yang R, Zhu Q, Feng Z Int J Clin Exp Pathol. 2020; 11(8):4052-4059.

PMID: 31949795 PMC: 6962820.